Valproate decreases inositol biosynthesis

Biological Psychiatry

Volumn 56, Issue 11, 2004, Pages 868-874

  Shaltiel, Galit ^a   Shamir, Alon ^a   Shapiro, Joseph ^a   Ding, Daobin ^c   Dalton, Emma ^d   Bialer, Meir ^b   Harwood, Adrian J ^d   Belmaker, Robert H ^a   Greenberg, Miriam L ^c   Agam, Galila ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

brain; dorsal root ganglia growth cones; inositol; myo inositol 1 phosphate synthase; psychotropic drugs; Valproic acid

Indexed keywords

AMIDE; ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; CYCLOPROPANE DERIVATIVE; HALOPERIDOL; IMIPRAMINE; INOSITOL; LAMOTRIGINE; MYOINOSITOL 1 PHOSPHATE SYNTHASE; N METHYL 2,2,3,3 TETRAMETHYLCYCLOPROPANE CARBOXAMIDE; NEUROLEPTIC AGENT; PHENYTOIN; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID; VALPROMIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FRONTAL CORTEX; GAS CHROMATOGRAPHY; GROWTH CONE; HOMOGENATE; HUMAN; HUMAN TISSUE; MALE; MORPHOLOGY; MOUSE; NERVE CELL CULTURE; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; UPREGULATION;

AMIDES; ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; BLOTTING, NORTHERN; BRAIN CHEMISTRY; CELLS, CULTURED; CHROMATOGRAPHY, GAS; CYCLOPROPANES; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; GENE EXPRESSION; HUMANS; INOSITOL; MALE; MICE; MICE, INBRED ICR; MYO-INOSITOL-1-PHOSPHATE SYNTHASE; NEURONS; POSTMORTEM CHANGES; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SACCHAROMYCES CEREVISIAE; VALPROIC ACID;

EID: 9644276924     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.08.027     Document Type: Article

References (53)

1. G. Agam, Y. Shapiro, Y. Bersudsky, O. Kofman, R.H. Belmaker High-dose peripheral inositol raises brain inositol levels and reverses behavioral effects of inositol depletion by lithium Pharmacol Biochem Behav 49 1994 341 343
2. B.P. Ashburner, J.M. Lopes Regulation of yeast phospholipid biosynthetic gene expression in response to inositol involves two superimposed mechanisms Proc Natl Acad Sci U S A 92 1995 9722 9726
3. J.E. Barnett, R.E. Brice, D.L. Corina A colorimetric determination of inositol monophosphates as an assay for D-glucose 6-phosphate-1L-myoinositol 1-phosphate cyclase Biochem J 119 1970 183 186
4. R.H. Belmaker, G. Agam, D. van Calker, M.H. Richards, O. Kofman Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle Depletion by chronic lithium of brain inositol is specific to hypothalamus and inositol levels may be abnormal in postmortem brain from bipolar patients Neuropsychopharmacology 19 1998 220 232
5. M.J. Berridge Phosphoinositides and signal transductions Rev Clin Basic Pharm 5 suppl 1985 5S 13S
6. Y. Bersudsky, Z. Kaplan, Y. Shapiro, G. Agam, O. Kofman, R.H. Belmaker Behavioral evidence for the existence of two pools of cellular inositol Eur Neuropsychopharmacol 4 1994 463 467
7. M. Bialer Clinical pharmacology of valpromide Clin Pharmacokinet 20 1991 114 122
8. M. Bialer, S. Hadad, B. Kadry, A. Abdul-Hai, A. Haj-Yehia, J. Sterling Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide Pharm Res 13 1996 284 289
9. C.D. Bown, J.F. Wang, B. Chen, L.T. Young Regulation of ER stress proteins by valproate Therapeutic implications Bipolar Disord 4 2002 145 151
10. W.B. Busa, R.L. Gimlich Lithium-induced teratogenesis in frog embryos prevented by a polyphosphoinositide cycle intermediate or a diacylglycerol analog Dev Biol 132 1989 315 324
11. G.M. Carman, S.A. Henry Phospholipid biosynthesis in the yeast Saccharomyces cerevisiae and interrelationship with other metabolic processes Prog Lipid Res 38 1999 361 399
12. T.L. Casebolt, R.S. Jope Long-term lithium treatment selectively reduces receptor-coupled inositol phospholipid hydrolysis in rat brain Biol Psychiatry 25 1989 329 340
13. G. Chen, W.Z. Zeng, P.X. Yuan, L.D. Huang, Y.M. Jiang, Z.H. Zhao The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS J Neurochem 72 1999 879 882
14. N.R. Council Guide for the Care and Use of Laboratory Animals 1996 National Academy Press Washington, DC
15. J.F. Dixon, L.E. Hokin The anti-bipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates Proc Natl Acad Sci U S A 94 1997 4757 4760
16. Y. Eilam Membrane effects of phenothiazines in yeasts. I. Stimulation of calcium and potassium fluxes Biochim Biophys Acta 733 1983 242 248
17. Y. Eilam, H. Lavi, N. Grossowicz Active extrusion of potassium in the yeast Saccharomyces cerevisiae induced by low concentrations of trifluoperazine J Gen Microbiol 131 1985 2555 2564
18. F. Eisenberg Jr D-myoinositol 1-phosphate as product of cyclization of glucose 6-phosphate and substrate for a specific phosphatase in rat testis J Biol Chem 242 1967 1375 1382
19. E.A. Elion, J.R. Warner The major promoter element of rRNA transcription in yeast lies 2 kb upstream Cell 39 1984 663 673
20. P.P. Godfrey, S.J. McClue, A.M. White, A.J. Wood, D.G. Grahame-Smith Subacute and chronic in vivo lithium treatment inhibits agonist- and sodium fluoride-stimulated inositol phosphate production in rat cortex J Neurochem 52 1989 498 506
21. M.L. Greenberg, J.M. Lopes Genetic regulation of phospholipid biosynthesis in Saccharomyces cerevisiae Microbiol Rev 60 1996 1 20
22. R. Gross-Isseroff, D. Salama, M. Israeli, A. Biegon Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem Effect of suicide Brain Res 507 1990 208 215
23. L.M. Hallcher, W.R. Sherman The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain J Biol Chem 255 1980 10896 10901
24. L. Hertz, M. Wolfson, E. Hertz, G. Agam, M. Richards, R.H. Belmaker Lithium-inositol interactions Synthesis, uptake, turnover A. Honig H.M. Van Praag Depression Neurobiological, Psychopathological and Therapeutic Advances 1997 John Wiley & Sons Chichester, United Kingdom 519 534
25. N. Isoherranen, H.S. White, R.H. Finnell, B. Yagen, J.H. Woodhead, G.D. Bennett Anticonvulsant profile and teratogenicity of N-methyl- tetramethylcyclopropyl carboxamide A new antiepileptic drug Epilepsia 43 2002 115 126
26. R.S. Jope Anti-bipolar therapy Mechanism of action of lithium Mol Psychiatry 4 1999 117 128
27. R.S. Jope, M.B. Williams Lithium and brain signal transduction systems Biochem Pharmacol 47 1994 429 441
28. S. Ju, G. Shaltiel, A. Shamir, G. Agam, M.L. Greenberg Human 1-D-myo-inositol-3-phosphate synthase is functional in yeast J Biol Chem 279 2004 21759 21765
29. D.A. Kendall, S.R. Nahorski Acute and chronic lithium treatments influence agonist and depolarization-stimulated inositol phospholipid hydrolysis in rat cerebral cortex J Pharmacol Exp Ther 241 1987 1023 1027
30. O. Kofman, R.H. Belmaker Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral and clinical studies of the role of inositol in lithium treatment and depression Biol Psychiatry 34 1993 839 852
31. O. Kofman, R.H. Belmaker, N. Grisaru, C. Alpert, I. Fuchs, V. Katz Myo-inositol attenuates two specific behavioral effects of acute lithium in rats Psychopharmocol Bull 27 1991 185 190
32. D.G. Lang, C.M. Wang, B.R. Cooper Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells J Pharmacol Exp Ther 266 1993 829 835
33. W. Loscher Valproate A reappraisal of its pharmacodynamic properties and mechanisms of action Prog Neurobiol 58 1999 31 59
34. W. Loscher Basic pharmacology of valproate A review after 35 years of clinical use for the treatment of epilepsy CNS Drugs 16 2002 669 694
35. T. Maeda, F. Eisenberg Jr Purification, structure and catalytic properties of L-myo-inositol-1-phosphate synthase from rat testis J Biol Chem 255 1980 8458 8464
36. A.L. Majumder, M.D. Johnson, S.A. Henry 1L-myo-inositol-1-phosphate synthase Biochim Biophys Acta 1348 1997 245 256
37. H.K. Manji, R.H. Lenox Long-term action of lithium A role for transcriptional and posttranscriptional factors regulated by protein kinase C Synapse 16 1994 11 28
38. H.K. Manji, W.Z. Potter, R.H. Lenox Signal transduction pathways. Molecular targets for lithium's actions Arch Gen Psychiatry 52 1995 531 543
39. F.F. Moebius, K. Bermoser, R.J. Reiter, M. Hanner, H. Glossmann Yeast sterol C8-C7 isomerase Identification and characterization of a high-affinity binding site for enzyme inhibitors Biochemistry 35 1996 16871 16878
40. C.M. Moore, J.L. Breeze, S.A. Gruber, S.M. Babb, B.B. Frederick, R.A. Villafuerte Choline, myo-inositol and mood in bipolar disorder A proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex Bipolar Disord 2 2000 207 216
41. M. Murray, M.L. Greenberg Regulation of inositol monophosphatase in Saccharomyces cerevisiae Mol Microbiol 25 1997 541 546
42. J.E. Novak, R.S. Turner, B.W. Agranoff, S.K. Fisher Differentiated human NT2-N neurons possess a high intracellular content of myo-inositol J Neurochem 72 1999 1431 1440
43. T. O'Donnell, S. Rotzinger, T.T. Nakashima, C.C. Hanstock, M. Ulrich, P.H. Silverstone Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain Brain Res 880 2000 84 91
44. C.J. Phiel, F. Zhang, E.Y. Huang, M.G. Guenther, M.A. Lazar, P.S. Klein Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer and teratogen J Biol Chem 276 2001 36734 36741
45. A. Shaldubina, S. Ju, D. Vaden, D. Ding, R.H. Belmaker, M.L. Greenberg Epi-inositol regulates expression of the yeast INO1 gene encoding inositol-1-P synthase Mol Psychiatry 7 2002 174 180
46. G. Shaltiel, A. Shamir, L. Nemanov, Y. Yaroslavsky, B. Nemets, R.P. Ebstein Inositol monophosphatase activity in brain and lymphocyte-derived cell lines of bipolar, schizophrenic and unipolar patients World J Biol Psychiatry 2 2001 95 98
47. A. Shamir, G. Shaltiel, M.L. Greenberg, R.H. Belmaker, G. Agam Lithium's effect on gene expression of inositol synthesis enzymes in mouse hippocampus Comparison with the yeast model Mol Brain Res 115 2003 104 110
48. J. Shapiro, R.H. Belmaker, A. Beigon, A. Seker, G. Agam Scyllo-inositol in post-mortem brain of suicide victims, bipolar, unipolar and schizophrenic patients J Neural Transm 107 2000 603 607
49. D.L. Vaden, D. Ding, B. Peterson, M.L. Greenberg Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis J Biol Chem 276 2001 15466 15471
50. M.M. Weissman, P.J. Leaf, G.L. Tischler, D.G. Blazer, M. Karno, M.L. Bruce, L.P. Florio Affective disorders in five United States communities Psychol Med 18 1988 141 153
51. R.D. Whitlow, A. Sacher, D.D. Loo, N. Nelson, S. Eskandari The anticonvulsant valproate increases the turnover rate of gamma -aminobutyric acid transporters J Biol Chem 278 2003 17716 17726
52. R.S. Williams, L. Cheng, A.W. Mudge, A.J. Harwood A common mechanism of action for three mood-stabilizing drugs Nature 417 2002 292 295
53. Y.H. Wong, S.J. Kalmbach, B.K. Hartman, W.R. Sherman Immunohistochemical staining and enzyme activity measurements show myo-inositol-1-phosphate synthase to be localized in the vasculature of brain J Neurochem 48 1987 1434 1442